ExCellThera launches trial of drug to expand umbilical cord blood for stem-cell transplants in cancer

Scientists at the University of Montreal have identified a small-molecule drug that could boost stem cell counts in umbilical cord blood—a potential boon for the treatment of blood cancer patients. They have early clinical data showing a quick expansion of blood cells as well as a low complication rate.